Response: Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea (Diabetes Metab J 2012;36:151-6)

Article information

Diabetes Metab J. 2012;36(3):253-253

Publication date (electronic) : 2012 June 14

doi : https://doi.org/10.4093/dmj.2012.36.3.253

Hong-Kyu Kim , Sung-Jin Bae , Jaewon Choe

Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea.

Corresponding author: Hong-Kyu Kim. Health Promotion Center, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. hkkim0801@amc.seoul.kr

Thank you for your interest and comments on our study, "Impact of HbA1c criterion on the detection of subjects with increased risk for diabetes among health check-up recipients in Korea" published in Diabetes & Metabolism Journal 2012;36;151-6.

Regarding the standardization of A1c value, we measured A1c by ion-exchange high-performance liquid chromatography using an automated analyzer (Variant II™; Bio-Rad Laboratories, Hercules, CA, USA), which has already been aligned to the Diabetes Control and Complications Trial (DCCT) reference standard and certified by the National Glycohemoglobin Standardization Program [1,2].

Notes

No potential conflict of interest relevant to this article was reported.

References

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34(Suppl 1):S62–S69. 21193628.

2. List of NGSP certified methods. National Glycohemoglobin Standardization Program updated 2012 Jun 1. Available from: http://www.ngsp.org/docs/methods.pdf.

Article information Continued

(open-access, http://creativecommons.org/licenses/by-nc/3.0/) :

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.